Executive Board

The Executive Board is responsible for managing the company. Its members are jointly accountable for the management of the company. The Executive Board has, as its prime responsibility, the group's strategic management, resource allocation, financial accounting and reporting, risk management, and corporate control.

Dr. Harald Hasselmann
Chairman of the Executive Board (CEO)
Segment Medical

Born 1967
After completing his doctorate studies in economics he gained experience at various international pharmaceutical companies. He has held various positions in large and medium-sized healthcare companies and has an excellent track record in sales, finance and implementing restructuring measures. Since 2015, he has been Managing Director of Eckert & Ziegler BEBIG GmbH. In 2017 he was appointed to the Executive Board of Eckert & Ziegler. As of June 8, 2023, he has become Chairman of the Executive Board.

Jutta Ludwig
Member of the Executive Board
Asia Business

Born 1953
After studying economics and sinology in Hamburg and Taiwan, Ms. Ludwig held various positions in German-Chinese economic cooperation. She was the managing director of the German Chamber of Commerce Abroad in Beijing for many years. She is a proven expert in business and economic policy cooperation with China and Asia. Since January 2023, Ms Ludwig is responsible for the Group's Asian business within the Executive Board of Eckert & Ziegler AG.

Frank Yeager
Member of the Executive Board
Segment Isotope Products

Born 1958
After graduating in business administration (MBA) and mechanical engineering, Mr. Yeager held leading positions in international industrial companies. In 2001, he joined the American subsidiary Eckert & Ziegler Isotope Products, Inc. as managing director and has since been responsible for the Isotope Products segment. In 2023, he was appointed to the Executive Board.